NASDAQ · Biotechnology

QSI (QSI) Stock

$0.81 +7.87% NASDAQ: QSI Healthcare

Valuation

MetricValue
Price$0.81
Market Cap$161.11M
P/E Ratio-1.71
P/B Ratio0.78
P/S Ratio93.54
EPS (TTM)$-0.51
52-Week High$3.10
52-Week Low$0.69
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-45.91%
ROA-41.06%
ROCE-43.89%
Gross Margin-4900.00%
Operating Margin-4850.00%
Net Margin-56.06%
Debt/Equity0.02
Current Ratio7.65

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$1.0M$3.0M$2.0M
Operating Profit$-97.0M$-124.0M$-111.0M$-109.0M$-97.0M
Net Profit$-95.0M$-132.0M$-96.0M$-101.0M$-101.0M
EPS$-1.19$-0.95$-0.68$-0.71$-0.51
Op Margin——-10274.6%-3550.6%-3996.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$503.0M$391.0M$298.0M$248.0M$246.0M
Total Liabilities$26.0M$33.0M$27.0M$32.0M$25.0M
Cash$36.0M$84.0M$134.0M$49.0M$22.0M
Borrowings$8.0M$17.0M$15.0M$13.0M$4.0M

Latest News

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire · Jun 16, 2026 Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™ Business Wire · Jun 10, 2026 Quantum-Si Announces the Expansion of the Proteus™ Roadshow Business Wire · Jun 3, 2026 Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth? Simply Wall St. · May 31, 2026 Quantum-Si Q1 Earnings Call Highlights MarketBeat · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-67.0M$-91.0M$-94.0M$-88.0M$-95.0M
Investing Cash Flow$-457.0M$126.0M$138.0M$-37.0M$-31.0M
Financing Cash Flow$6.0M$-1.0M$0$1.0M$0
Net Cash Flow$-1.0M$49.0M$50.0M$-85.0M$-28.0M
Free Cash Flow$-73.0M$-101.0M$-99.0M$-92.0M$-97.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-55.24%
Quick Ratio12.40
Interest Coverage—
Return 1Y-49.94%
Return 3Y-64.21%
Return 5Y-92.70%

Ownership

Insiders Held10.51%
Institutions Held29.97%
Institutions Float Held33.49%
Institutional HolderSharesReport Date
Blackrock Inc.13,414,9492026-03-31
Vanguard Capital Management LLC7,021,9072026-03-31
ARK Investment Management, LLC6,878,8992026-03-31
Sumitomo Mitsui Trust Group, Inc.4,391,6662026-03-31
Amova Asset Management Americas Inc4,391,6662026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About QSI

QSI is led by CEO Jeffrey Alan Hawkins, publicly traded since 2020.

QSI stock trades at $0.81 with a market capitalization of $161.11M. The stock is valued at a price-to-earnings (P/E) ratio of -1.71, price-to-book of 0.78, price-to-sales of 93.54. Over the past 52 weeks the stock has ranged between $0.69 and $3.10, and currently trades 73.9% below its 52-week high.

On profitability, QSI generates a return on equity (ROE) of -45.91%, return on capital employed of -43.89%, an operating margin of -4850.00%, a net profit margin of -56.06%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides